Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

News & Events

Zika threat leads to Australian-first microcephaly study

WA Researchers have conducted an Australian-first study to determine the prevalence of microcephaly, in preparation of any future outbreak of the Zika virus.

News & Events

Lung problems continue into childhood for premmie babies

New research from Perth’s The Kids Research Institute Australia shows that babies born premature continue to have lung problems well into childhood.

News & Events

Premature babies at greater risk of childhood infection

New research has found children who are born even slightly premature or underweight are more likely to be hospitalised with an infection during their childhood

News & Events

Global war on brain cancer

Dr Nick Gottardo and Dr Raelene Endersby from The Kids Research Institute Australia are the driving force behind an innovative, global action group on child brain cancer.

News & Events

Making FASD history in the Fitzroy Valley

The Make FASD History campaign, led by community researchers and The Kids Research Institute Australia, has made huge inroads into prevention, diagnosis and therapy.

News & Events

On a quest for kids with cystic fibrosis

PRAGMA-CF, a new way of measuring early lung disease in young kids with cystic fibrosis is changing the way we detect and treat CF.

Research

AREST CF Early Surveillance Program

The Early Surveillance Program (ESP) is the platform upon which the AREST CF research program is based.

Research

Australia-Aotearoa Consortium for Epidemic Forecasting & Analytics (ACEFA)

The ACEFA NHMRC Centre of Research Excellence aims to support the timely, effective response to epidemic diseases in Australia through real-time data analytics, modelling, and forecasting.

Research

BCG vaccination to Reduce the impact of COVID-19 in Australian healthcare workers following Coronavirus Exposure (BRACE) Trial

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical

Research

Biomarkers to define the treatment end-point for pulmonary exacerbations in cystic fibrosis

Advances in our understanding of early cystic fibrosis lung disease led by the Australian Early Surveillance Team for Cystic Fibrosis (AREST CF) have also indicated the potential utility of a number of biomarkers for monitoring disease severity.